All results
4 results for randomized double blind placebo controlled study assess efficacy safety and
-
CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis
This is a Phase 2, multicenter, multinational, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, pharmacokinetics (PK),…
- Ages
- 40 Years - N/A
- Sexes
- All
-
GALACTIC-1
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and…
- Ages
- 40 Years - N/A
- Sexes
- All
-
TETON
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…
- Ages
- 40 Years - N/A
- Sexes
- All
-
Teton RIN-PF-301
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from…
- Ages
- 40 Years - N/A
- Sexes
- All